Compare TLX & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLX | GPOR |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | Australia | United States |
| Employees | 1184 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.5B |
| IPO Year | N/A | 1998 |
| Metric | TLX | GPOR |
|---|---|---|
| Price | $9.94 | $161.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 11 |
| Target Price | $21.13 | ★ $233.33 |
| AVG Volume (30 Days) | 190.6K | ★ 249.8K |
| Earning Date | 08-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 245.92 |
| EPS | N/A | ★ 8.87 |
| Revenue | N/A | ★ $1,422,583,000.00 |
| Revenue This Year | N/A | $18.35 |
| Revenue Next Year | N/A | $6.04 |
| P/E Ratio | $150.33 | ★ $18.49 |
| Revenue Growth | N/A | ★ 48.47 |
| 52 Week Low | $6.28 | $160.00 |
| 52 Week High | $17.25 | $225.78 |
| Indicator | TLX | GPOR |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 33.52 |
| Support Level | $9.46 | N/A |
| Resistance Level | $10.33 | $172.13 |
| Average True Range (ATR) | 0.27 | 4.42 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 86.21 | 18.51 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets located in the Appalachia and Anadarko basins in the United States. The principal properties of the company are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.